Skip to content

RYTM

Rhythm Pharmaceuticals, Inc.

Stock

$92.83−0.58 (−0.62%)Close Oct 2, 2026

Operating income, 2025
−$192M

Operating income

Operating income by fiscal year

PeriodOperating incomeYoY
2025−$192M—
2024−$266M—
2023−$184M—
2022−$179M—
2021−$170M—
2020−$137M—
2019−$146M—
2018−$78M—
2017−$32M—
2016−$26M—
2015−$11M—